TrialAnnals of surgery2022

A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.

Daniel Brock Hewitt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.